S-531011 as Monotherapy and in Combination With an Immune Checkpoint Inhibitor in Advanced or Metastatic Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Solid Tumors
Related studies linked through entity extraction aliases.
Continued Access Study for Participants Deriving Benefit in Pfizer-Sponsored Avelumab Parent Studies That Are Closing
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Phase Ib/II Trial of Envafolimab Plus Lenvatinib for Subjects With Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Milademetan in Advanced/Metastatic Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE2
A Phase 1b Study of ZN-c3 in Chinese Subjects
- Status
- UNKNOWN
- Phase
- PHASE1
Study of ASP0739 Alone and With Pembrolizumab in Advanced Solid Tumors With NY-ESO-1 Expression Participants
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Microtransplantation for Advanced and Relapsed Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
IBI188 Combination Therapy in Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
A Study to Evaluate Safety, Pharmacokinetics and Anti-Tumor Activity of RO7300490, as Single Agent or in Combination With Atezolizumab in Participants With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Pilot Study of Thermodox and MR-HIFU for Treatment of Relapsed Solid Tumors
- Status
- WITHDRAWN
- Phase
- PHASE2
Dose Escalation of RMC-5552 Monotherapy in Relapsed/Refractory Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Study of ES102 (OX40 Agonist) in Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Study Investigating Safety,Tolerability,Pharmacokinetics and Antitumor Activities of HBM4003 Combine With Toripalimab
- Status
- UNKNOWN
- Phase
- PHASE1
Expanded Access Program for Avapritinib
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
A Trial to Learn Whether Regorafenib in Combination With Nivolumab Can Improve Tumor Responses and How Safe it is for Participants With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE2
A Phase I/II Clinical Trial of ICP-723 in the Treatment of Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
To Assess the Safety, Tolerability and Pharmacokinetics of INCB086550
- Status
- TERMINATED
- Phase
- PHASE1
A Bioequivalence Study Between the Proposed and Current Talazoparib Capsule Formulation and Food Effect Study for the Proposed Talazoparib Capsule Formulation in Participants With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Test Different Doses of BI 765063 Alone and in Combination With BI 754091 in Japanese Patients With Different Types of Advanced Cancer (Solid Tumors)
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Evaluate the Safety and Tolerability of RO7296682 in Combination With Atezolizumab in Participants With Advanced Solid Tumors.
- Status
- TERMINATED
- Phase
- PHASE1